Member of the Board of Directors of Genomed S.A.
In 2010, she graduated Medical analytics at the Jagiellonian University Medical College, obtaining the title and qualifications of a laboratory diagnostician (license no. 13335) and then postgraduate studies in molecular biology at the Faculty of Biochemistry, Biophysics and Biotechnology of the Jagiellonian University in Cracow. Continuing education and lifelong learning activities, she began specialization in Laboratory Medical Genetics in 2015.
From 2014 to 2017 she was the head of the Molecular Biology Laboratory at Diagnostyka Sp. z o.o. in Cracow. Afterwards, she took the position of the Specialist for the development of molecular biology and genetics in the Department of Marketing and Scientific Information, she created marketing and sales strategies and was responsible for the development and presentation of the genetic research offer. Simultaneously, since 2016, as an expert on genetics, she represented the company by publishing her own texts in media and at training sessions for specialist physicians and laboratory diagnosticians.
After the acquisition of Centra Genetyki Medycznej Genesis in Poznań by Diagnostyka Sp. z o.o. in 2018, she was appointed as the Management Board Proxy supporting laboratory processes, and since January 2020 as a Member of the Board of Directors of the Genesis. Since 2019, she became the Director of Strategic Planning and Genetic Research Development in the company Diagnostyka Sp. o.o. In June 2019, Diagnostyka Sp. z o.o. has exercised the shareholder entitlements to personal board representation, as a result of which Anna Piotrowska-Mietelska was appointed as a Member of the Board of Directors of Genomed S.A.
In the last 5 years, Anna Piotrowska-Mietelska has not been convicted of crimes or fraud and has not received a court ban on acting as a member of management or supervisory bodies, in commercial law companies. During 5 years period, there was no bankruptcy, receivership or liquidation of the entity in which Anna Piotrowska-Mietelska was a member of the supervisory board or management body.
Neither Anna Piotrowska-Mietelska conducts activities competitive to Genomed S.A. nor is participating in a competitive company as a partner in a civil law partnership, partnership or as a member of the body of a competitive limited company or a member of the body of any competitive legal entity, except for:
- Diagnostyka sp. z o.o. as the Director of Strategic Planning and Genetic Research Development;
- Centra Genetyki Medycznej Genesis sp. z o.o. as a Member of the Board of Directors,
for which she obtained the consent of the Supervisory Board of the Genomed S.A.
Anna Piotrowska-Mietelska is not entered in the Register of Insolvent Debtors kept pursuant to the Act of 20 August 1997 on the National Court Register. Anna Piotrowska-Mietelska is related to a shareholder holding shares representing not less than 5% of the total number of votes at the General Meeting of a company (Diagnostyka sp. z o.o. as the Director of Strategic Planning and Genetic Research Development and as the Member of the Board of Directors of the Centra Genetyki Medycznej Genesis sp. z o.o., in which 100% of shares belong to the Diagnostyka sp. z o.o.).
Anna Piotrowska-Mietelska during the last 3 years or more, has not been a member of the management or supervisory bodies or a partner in a commercial law company except as mentioned above.
